Antibody for Infant RSV Prevention to Face FDA Panel

(MedPage Today) -- An FDA advisory committee on Thursday will consider whether to recommend a shot of a monoclonal antibody against respiratory syncytial virus (RSV) to prevent lower respiratory tract disease in both infants and in at-risk children...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news